폐암 수술 시장 : 제품 유형별, 수술 유형별, 시술별, 암스테이지별, 최종사용자별, 지역별

Lung Cancer Surgery Market, By Product Type, By Surgery Type, By Procedure, By Cancer Stage, By End user, By Geography

US $ 4,500 ￦ 6,483,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000 ￦ 10,085,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,408,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

폐암 수술 시장은 2025년에 66억 1,000만 달러, 2032년에는 90억 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 4.5%를 나타낼 전망입니다.

분석 범위		분석 상세
기준 연도	2024년	시장 규모(2025년)	66억 1,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 CAGR(2025-2032년)	4.50%	예측 금액(2032년)	90억 달러

폐암은 사람이 숨을 들이마실 때 산소를 받아들이고 내쉴 때 이산화탄소를 배출하는 가슴에 있는 두 개의 스펀지 모양의 기관인 폐에서 발생하는 암의 일종입니다. 폐암은 세계에서 가장 흔하게 발생하는 암 중 하나이며, 암으로 인한 사망의 주요 원인입니다.

폐암 수술은 암에 걸린 종양이나 폐의 일부를 제거하기 위해 시행하는 의료 행위입니다. 수술의 유형은 폐 종양의 크기와 위치, 폐암의 유형(비소세포폐암 또는 소세포폐암), 환자의 전신 상태에 따라 달라집니다. 폐암 수술에는 폐엽절제술, 폐절제술, 폐분절절제술 등 여러 유형이 있습니다. 폐암 수술은 이 공격적인 질병을 치료하기 위한 매우 중요한 접근법입니다. 의료 전문가는 영향을 받은 폐 조직을 외과적으로 제거함으로써 국소화된 종양을 겨냥하여 효과적인 치료와 완치 가능성을 제공할 수 있습니다. 이 수술의 성공 여부는 조기 발견, 정확한 병기, 환자의 전신 상태에 달려 있습니다. 전통적인 개복 수술부터 VATS(비디오 보조 흉강경 수술)와 같은 최소 침습적 기술까지, 폐암 수술은 외상을 최소화하고 회복 속도를 높이기 위해 진화해 왔습니다. 폐암 수술은 폐암에 대한 다학제적 싸움에서 매우 중요한 요소로 남아 있습니다.

시장 역학:

폐암 유병률 증가는 예측 기간 동안 세계 폐암 수술 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2022년 3월 세계 암 연구 기금 인터내셔널(World Cancer Research Fund International)이 발표한 데이터에 따르면, 2020년 전 세계적으로 220만 명 이상의 폐암 신규 환자가 발생했습니다.

본 보고서의 주요 특징

• 세계의 폐암 수술 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 세계 폐암 수술 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 작성되었습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• "세계 폐암 수술 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 폐암 수술 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매 및 승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 세계의 폐암 수술 시장 : 신형 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 폐암 수술 시장 : 제품 유형별(2020-2032년)

• 수술 기구
• 모니터링 및 시각화 시스템
• 내시경 수술 기기
• 로봇 지원 흉부 수술 시스템
• 기타

제6장 세계의 폐암 수술 시장 : 수술 유형별(2020-2032년)

• 개복 수술
• 저침습 수술

제7장 세계의 폐암 수술 시장 : 시술별(2020-2032년)

• 폐엽 절제술
• 분절 절제술 및 쐐기 절제술
• 폐 절제술
• 슬리브 절제술
• 확장 절제

제8장 세계의 폐암 수술 시장 : 암 단계별(2020-2032년)

• 초기 단계
• 후기 단계

제9장 세계의 폐암 수술 시장 : 최종사용자별(2020-2032년)

• 병원
• 외래수술센터(ASC)
• 전문 클리닉

제10장 세계의 폐암 수술 시장 : 지역별(2020-2032년)

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제11장 경쟁 구도

• Ethicon(Johnson & Johnson)
• Medtronic
• Intuitive Surgical
• Olympus Corporation
• Karl Storz
• Accuray Incorporated
• AngioDynamics
• Varian Medical Systems
• Siemens Healthineers
• Atricure, Inc.
• Novadaq Technologies Inc.
• GE Healthcare
• Scanlan International Inc

제12장 섹션

• 분석 방법
• 출판사에 대해

LSH

영문 목차

영문목차

Lung Cancer Surgery Market is estimated to be valued at USD 6.61 Bn in 2025 and is expected to reach USD 9.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 6.61 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.50%	2032 Value Projection:	USD 9.00 Bn

Lung cancer is a type of cancer that begins in the lungs, which are two spongy organs in chest that take in oxygen when a person inhale and release carbon dioxide when a person exhale. It is one of the most common cancers in the world and is a leading cause of cancer deaths.

Lung cancer surgery is a medical procedure performed to remove a tumor or a portion of the lung affected by cancer. The type of surgery depends on the size and location of the tumor in the lung, the type of lung cancer (non-small cell or small cell lung cancer), and the patient's overall health. There are several types of lung cancer surgeries such as lobectomy, segmentectomy, etc. Lung cancer surgery stands as a pivotal approach to treating this aggressive disease. By surgically removing affected lung tissue, medical professionals can target localized tumors, offering a chance for effective treatment and the potential cure. The procedure's success relies on early detection, accurate staging, and the patient's overall health. From traditional open surgeries to minimally invasive techniques like VATS (Video-Assisted Thoracoscopic Surgery), lung cancer surgery has evolved to minimize trauma and enhance recovery. It remains a crucial component in the multidisciplinary battle against lung cancer.

Market Dynamics:

The increasing prevalence of lung cancer is expected to drive the growth of the global lung cancer surgery market over the forecast period. For instance, according to data published in March 2022 by the World Cancer Research Fund International, globally, there were more than 2.2 million new cases of lung cancer in 2020.

Key features of the study:

• This report provides in-depth analysis of the global lung cancer surgery market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global lung cancer surgery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, Olympus Corporation, Karl Storz, Accuray Incorporated, AngioDynamics, Varian Medical Systems, Siemens Healthineers, Atricure, Inc., Novadaq Technologies Inc., GE Healthcare and Scanlan International Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global lung cancer surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer surgery market

Lung cancer surgery market Detailed Segmentation:

• By Product Type:
  • Surgical Instruments
  • Monitoring & Visualizing System
  • Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems
  • Others
• By Surgery Type:
  • Open Surgery
  • Minimally Invasive Surgery
• By Procedure:
  • Lobectomy
  • Segmentectomy/Wedge Resection
  • Pneumonectomy
  • Sleeve Resection
  • Extended Resection
• By Cancer Stage:
  • Early-Stage
  • Advanced-Stage
• By End user:
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
• By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Ethicon (Johnson & Johnson)
  • Medtronic
  • Intuitive Surgical
  • Olympus Corporation
  • Karl Storz
  • Accuray Incorporated
  • AngioDynamics
  • Varian Medical Systems
  • Siemens Healthineers
  • Atricure, Inc.
  • Novadaq Technologies Inc.
  • GE Healthcare
  • Scanlan International Inc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Lung Cancer Surgery, By Surgery Type
  • Market Lung Cancer Surgery, By Product Type
  • Market Lung Cancer Surgery, By Procedure
  • Market Lung Cancer Surgery, By Cancer Stage
  • Market Lung Cancer Surgery, By End User
  • Market Lung Cancer Surgery , By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of lung cancer
  • Restraints
• High Cost of Lung Cancer Surgery
  • Opportunities
• Adoption of Minimally Invasive Techniques
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Lung Cancer Surgery Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Lung Cancer Surgery Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Surgical Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Monitoring & Visualizing System
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Endosurgical Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Robotic-Assisted Thoracic Surgery Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Lung Cancer Surgery Market, By Surgery Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Open Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Minimally Invasive Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Lung Cancer Surgery Market, By Procedure, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Lobectomy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
• Segmentectomy/Wedge Resection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
• Pneumonectomy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
• Sleeve Resection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
• Extended Resection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

8. Global Lung Cancer Surgery Market, By Cancer Stage, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Early-Stage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
• Advanced-Stage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Lung Cancer Surgery Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

10. Global Lung Cancer Surgery Market, By Geography, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 - 2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

11. Competitive Landscape

• Ethicon (Johnson & Johnson)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Intuitive Surgical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Olympus Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Karl Storz
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Accuray Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AngioDynamics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Varian Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Atricure, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novadaq Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Scanlan International Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us

관련자료